1. Characteristics of myeloproliferative neoplasms in patients exposed to ionizing radiation following the Chernobyl nuclear accident. Issue 1 (31st October 2018) Authors: Poluben, Larysa; Puligandla, Maneka; Neuberg, Donna; Bryke, Christine R.; Hsu, Yahsuan; Shumeiko, Oleksandr; Yuan, Xin; Voznesensky, Olga; Pihan, German; Adam, Miriam; Fraenkel, Ernest; Rasnic, Roni; Linial, Michal; Klymenko, Sergiy; Balk, Steven P.; Fraenkel, Paula G. Journal: American journal of hematology Issue: Volume 94:Issue 1(2019:Jan.) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington's disease mice. (7th November 2019) Authors: Kedaigle, Amanda J; Reidling, Jack C; Lim, Ryan G; Adam, Miriam; Wu, Jie; Wassie, Brook; Stocksdale, Jennifer T; Casale, Malcolm S; Fraenkel, Ernest; Thompson, Leslie M Journal: Human molecular genetics Issue: Volume 29:Number 2(2020) Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗